Literature DB >> 10226329

Localization and regulation of nitric oxide synthase isoforms in the kidney.

B C Kone1.   

Abstract

Nitric oxide synthases (NOS), which comprise a multi-gene family, play important roles in a variety of physiological and pathophysiological processes in the kidney. The three major NOS isoforms are expressed in a cell type--specific manner and are subject to complex and distinct control mechanisms. Although knowledge about the intrarenal distribution and regulation of the major NOS isoforms has been expanding, recent advances in the molecular details of the structure, function, and regulation of the NOS genes and the enzymes they encode have added considerable complexity to the effort. Molecular biological studies have identified alternative splice variants of NOS1 and NOS2 that appear to be subject to unique regulation and may encode functionally distinct proteins. The renal distribution of these new variants has yet to be explored in detail. In addition, newly discovered transcriptional and posttranscriptional control mechanisms, including alternative promoter usage, protein-protein interactions, and phosphorylation events, for the three major NOS isoforms await characterization in renal cells. This review highlights the current state of knowledge about the distribution and regulation of the NOS isoforms in the kidney, and identifies new opportunities for further renal investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226329

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

Review 1.  Nitric oxide synthesis in the adult and developing kidney.

Authors:  Ki-Hwan Han; Ju-Young Jung; Ku-Yong Chung; Hyang Kim; Jin Kim
Journal:  Electrolyte Blood Press       Date:  2006-03

2.  Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4.

Authors:  Bo Holmqvist; Christina Falk Olsson; Maj-Lis Svensson; Catharina Svanborg; Johan Forsell; Per Alm
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

3.  Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.

Authors:  Marcel Dautzenberg; Gerburg Keilhoff; Armin Just
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

4.  Renal cell markers: lighthouses for managing renal diseases.

Authors:  Shivangi Agarwal; Yashwanth R Sudhini; Onur K Polat; Jochen Reiser; Mehmet M Altintas
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-11

5.  Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension.

Authors:  Ivanka Mikulić; József Petrik; Kresimir Galesić; Zeljko Romić; Ivana Cepelak; Monika Zeljko-Tomić
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 6.  Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.

Authors:  Matthieu Legrand; Egbert G Mik; Tanja Johannes; Didier Payen; Can Ince
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

7.  Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse.

Authors:  Takahiro Nakayama; Waichi Sato; Tomoki Kosugi; Li Zhang; Martha Campbell-Thompson; Ashio Yoshimura; Byron P Croker; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-26

8.  Nitric oxide synthase and renin-angiotensin gene expression and NOS function in the postnatal renal resistance vasculature.

Authors:  Brian Ratliff; Justin Rodebaugh; Miroslav Sekulic; Ke-Wen Dong; Michael Solhaug
Journal:  Pediatr Nephrol       Date:  2008-10-03       Impact factor: 3.714

Review 9.  Effects of Nitric Oxide on Renal Proximal Tubular Na+ Transport.

Authors:  Nobuhiko Satoh; Motonobu Nakamura; Atsushi Suzuki; Hiroyuki Tsukada; Shoko Horita; Masashi Suzuki; Kyoji Moriya; George Seki
Journal:  Biomed Res Int       Date:  2017-10-17       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.